293 related articles for article (PubMed ID: 30152569)
21. Acute generalized exanthematous pustulosis induced by generic hydroxychloroquine.
Wang G; Zhuo N; Li J
J Cosmet Dermatol; 2022 Aug; 21(8):3608-3610. PubMed ID: 34757679
[No Abstract] [Full Text] [Related]
22. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
[No Abstract] [Full Text] [Related]
23. Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
Schwartz RA; Janniger CK
Dermatol Ther; 2020 May; 33(3):e13380. PubMed ID: 32253799
[TBL] [Abstract][Full Text] [Related]
24. [Acute generalized exanthematic pustulosis induced by hydroxychloroquine: case report].
Djennane M; Tablit I; Billhot M; Banal F
Rev Med Interne; 2010 Mar; 31(3):e7-8. PubMed ID: 20089332
[TBL] [Abstract][Full Text] [Related]
25. Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test.
Salman A; Yucelten D; Akin Cakici O; Kepenekli Kadayifci E
Pediatr Dermatol; 2019 Jul; 36(4):514-516. PubMed ID: 31050838
[TBL] [Abstract][Full Text] [Related]
26. Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Tsurane K; Kaneko K; Yoshida K; Tanaka R; Sago H; Murashima A
Mod Rheumatol Case Rep; 2023 Jun; 7(2):373-377. PubMed ID: 36420890
[TBL] [Abstract][Full Text] [Related]
27. Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
Robustelli Test E; Vezzoli P; Carugno A; Raponi F; Gianatti A; Rongioletti F; Sena P
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e457-e459. PubMed ID: 32386448
[No Abstract] [Full Text] [Related]
28. Rapid clearing of acute generalized exanthematous pustulosis after administration of ciclosporin.
Di Lernia V; Grenzi L; Guareschi E; Ricci C
Clin Exp Dermatol; 2009 Dec; 34(8):e757-9. PubMed ID: 19663832
[TBL] [Abstract][Full Text] [Related]
29. First case report of acute generalized exanthematous pustulosis (AGEP) caused by mifepristone.
Zhang L; Qian M; Hong L; Wu Q
Contact Dermatitis; 2020 Mar; 82(3):177-179. PubMed ID: 31626328
[No Abstract] [Full Text] [Related]
30. [Hydroxychloroquine-puvatherapy photoinduced acute generalized exanthematous pustulosis].
Bonnetblanc JM; Combeau A; Dang PM
Ann Dermatol Venereol; 1995; 122(9):604-5. PubMed ID: 8745685
[TBL] [Abstract][Full Text] [Related]
31. Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
Atak MF; Farabi B; Akbayrak A; Kalelioğlu MB; Rao BK
J Cosmet Dermatol; 2021 Aug; 20(8):2387-2389. PubMed ID: 34139069
[No Abstract] [Full Text] [Related]
32. Successful Treatment of Hydroxychloroquine-Induced Recalcitrant Acute Generalized Exanthematous Pustulosis with Cyclosporine: Case Report and Literature Review.
Yalçın B; Çakmak S; Yıldırım B
Ann Dermatol; 2015 Aug; 27(4):431-4. PubMed ID: 26273160
[TBL] [Abstract][Full Text] [Related]
33. [Acute cutaneous pustular eruption due to hydroxychloroquine].
Pastushenko I; Gracia-Cazaña T; Morales-Moya AL; Grasa MP
Med Clin (Barc); 2014 Oct; 143(7):e13. PubMed ID: 24908623
[No Abstract] [Full Text] [Related]
34. Acute generalized exanthematous pustulosis associated with 2 common medications: hydroxyzine and benzocaine.
O'Toole A; Lacroix J; Pratt M; Beecker J
J Am Acad Dermatol; 2014 Oct; 71(4):e147-9. PubMed ID: 25219740
[No Abstract] [Full Text] [Related]
35. Two cases of annular acute generalized exanthematous pustulosis induced by terbinafine.
Olivier S; De Montjoye L; Tromme I; Baeck M
Eur J Dermatol; 2018 Apr; 28(2):236-238. PubMed ID: 29336314
[No Abstract] [Full Text] [Related]
36. Acute generalized exanthematous pustulosis associated with ranolazine.
Grelck K; Stewart N; Rosen L; Sukal S
Cutis; 2015 Oct; 96(4):E18-21. PubMed ID: 26682297
[TBL] [Abstract][Full Text] [Related]
37. Acute generalized exanthematous pustulosis induced by isotretinoin.
da Cunha Filho RR; de Almeida HL; Lorencette NA; Fillus Netto J
Int J Dermatol; 2010 Sep; 49(9):1077-9. PubMed ID: 20883276
[No Abstract] [Full Text] [Related]
38. Acute generalized exanthematous pustulosis induced by celecoxib.
Lee SK; Lee DY; Kim DJ; Kim MS; Lee UH; Hahm JH
J Cutan Pathol; 2016 Jan; 43(1):80-1. PubMed ID: 26488335
[No Abstract] [Full Text] [Related]
39. Hydroxychloroquine-induced acute generalized exanthematous pustulosis in an orofacial granulomatosis patient with homozygous IL36RN mutation.
Yan C; Shang Q; Geng S
Dermatol Ther; 2022 Aug; 35(8):e15587. PubMed ID: 35575468
[No Abstract] [Full Text] [Related]
40. Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
Alniemi DT; Wetter DA; Bridges AG; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT
Int J Dermatol; 2017 Apr; 56(4):405-414. PubMed ID: 28084022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]